Changes in metabolic parameters and body shape after replacement of protease inhibitor With efavirenz in virologically controlled HIV-1-positive persons: single-arm observational cohort

J Acquir Immune Defic Syndr. 2001 Dec 1;28(4):399-401. doi: 10.1097/00126334-200112010-00016.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Alkynes
  • Anti-HIV Agents / therapeutic use*
  • Benzoxazines
  • Body Constitution
  • Body Weight
  • Cohort Studies
  • Cyclopropanes
  • Female
  • HIV Infections / drug therapy*
  • HIV Infections / metabolism
  • HIV-1*
  • Humans
  • Male
  • Middle Aged
  • Oxazines / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use*

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • efavirenz